Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05020678
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2021-08-20
Brief Title:
NKX019 Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells CAR NK in Adults With B-cell Cancers
Sponsor:
Nkarta Inc
Organization:
Nkarta Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma Non-Hodgkin |
| Large-cell Lymphoma |
| B-cell Acute Lymphoblastic Leukemia |
| Large B-cell Lymphoma |
| Mantle Cell Lymphoma |
| Indolent Lymphoma |
| Waldenstrom Macroglobulinemia |
| Chronic Lymphocytic Leukemia |
| Small Lymphocytic Lymphoma |
| Aggressive Lymphoma |
Keywords:
| Name | View |
|---|---|
| LCL | View |
| CD19 | View |
| CAR | View |
| Allogeneic | View |
| Natural killer | View |
| ACR | View |
| NKX019 | View |
| IL15 | View |
| Interleukin 15 | View |
| NK cell | View |
| Cell Therapy | View |
| Immunotherapy | View |
| Adoptive cell therapy | View |
| rr NHL | View |
| rr B-ALL | View |
| rr MCL | View |
| rr IL | View |
| rr WM | View |
| rr CLL | View |
| rr SLL | View |
| Aggressive lymphoma | View |
| Indolent lymphoma | View |